Drug Type Small molecule drug |
Synonyms Balofloxacin hydrate (JAN), Baloxin, Neuquinoron + [3] |
Action inhibitors |
Mechanism Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors), Bacterial top IV inhibitors(Bacterial topoisomerase IV inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (06 May 1993), |
Regulation- |
Molecular FormulaC20H24FN3O4 |
InChIKeyMGQLHRYJBWGORO-UHFFFAOYSA-N |
CAS Registry127294-70-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02463 | Balofloxacin | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bacterial Infections | South Korea | 06 May 1993 | |
Urinary Tract Infections | China | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial Infections | Preclinical | Japan | 01 Aug 1992 |